Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

 Nathan Cummins

Nathan Cummins

Mayo Clinic USA

Silvia Cacho-Elizondo

Silvia Cacho-Elizondo

IPADE Business School USA

Eleni Konstantinou

Eleni Konstantinou

Harvard Medical School USA

Cristina Damatarca

Cristina Damatarca

Agility Clinical USA

Flic Gabbay

Flic Gabbay

TranScrip UK

Zhihong Xu

Zhihong Xu

South College USA

Anika Staack

Anika Staack

MEDICE Germany

Gamal Hussein

Gamal Hussein

South College School of Pharmacy USA

Pharmacovigilance 2018

Sessions/Tracks

We solicit your gracious presence at the upcoming 11th International Conference and Exhibition on Pharmacovigilance and Drug Safety scheduled to happen during June 21-22, 2018 in Munich, Germany focussing on the advancements in emerging research and technologies in pharmacovigilance, clinical trials and risk management.

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Pharmacovigilance 2018 emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Theme: “Global Pharmacovigilance Approaches and Innovations for Patient Benefit Risk Management”

Track 1: Pre-Clinical and Clinical Trials

Clinical trials allow the drug to be tested for safety by different ethnic population. Due to the higher medical needs and increasing disease prevalence, developing countries are becoming a hub for clinical trial execution. The clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, and the annual growth rate of (7.5%). There are additionally numerous clinical trials started by scholarly clinical scientists. Whether started by industry or by scholastic clinical examiners and research is frequently performed in national, European and overall consortia, which can be expansive ones. Clinical research brings up moral and security issues. Clinical research is exceedingly controlled. To encourage and coordinated efforts crosswise over fringes.

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Conference on Pharmacology during September 04-06, 2017 at Paris, France; 3rd Conference on Advanced Clinical Research September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Conference on Pain Research and Management October 05-06, 2017 London, UK; 20th Conference on Pharmaceutical Biotechnology December 07-09, 2017 Madrid, Spain; 12th Conference on Pharmaceutical Sciences February 26- 27, 2018 London, UK; 16th Conference on Pharmaceutics March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th  Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th Conference on  Marine Drugs June 11-13, 2018 Rome, Italy

Related Associations or Societies:

Society for Clinical Trials (SCT), Association of Clinical ResearchThe Society of Clinical Research AssociatesAssociation of Clinical Research OrganizationClinical Research SocietyIndian Society for Clinical Organization Research (ISCR)

Track 2: Adverse Drug Reactions

Adverse drug reactions can be considered a form of toxicity or enhanced drug effects that occur during appropriate use (eg, when drug metabolism is temporarily inhibited by a disorder or another drug). In the US, 3 to 7% of all hospitalizations are due to adverse drug reactions. ADRs occur during 10 to 20% of hospitalizations; about 10 to 20% of these ADRs are severe. Incidence of death due to ADRs is unknown; suggested rates of 0.5 to 0.9% may be falsely high because many of the patients included had serious and complex disorders. Incidence and severity of adverse drug reactions vary by patient characteristics (eg, age, sex, ethnicity, coexisting disorders, genetic or geographic factors) and by drug factors (eg, type of drug, administration route, treatment duration, dosage, and bioavailability). Incidence is higher with advanced age and polypharmacy. 

Related Pharmacovigilance Conferences | Pharmacovigilance Meetings

9th Conference on Pharmacology September 04-06, 2017 Paris, France; 3rd Clinical Trials Conference September 20-21, 2017 Dublin, Ireland; 9th Conference on Pharmaceutical Chemical Analysis October 02-03, 2017 Vienna, Austria; 5th Conference on Pain Research and Management October 05-06, 2017 London, UK; Conference on Pharmaceutical Biotechnology December 07-09, 2017 Madrid, Spain; 12th Conference on Pharmaceutical Sciences in Pharma Industry February 26-27, 2018 London, UK; 16th Conference on Drug Delivery Systems March 19-21, 2018 Berlin, Germany; 11th European Biosimilars Conference  April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 at Frankfurt, Germany; 4th Conference on  Natural Products June 11-13, 2018 Rome, Italy

Related Associations or Societies:

American Association of Pharmaceutical ScientistsIndian Pharmaceutical AssociationAssociation of Clinical ResearchThe International Society of PharmacovigilanceCanadian Society of Pharmaceutical Sciences (CSPS), Association of Clinical Research Organization (ACRO)

Track 3: Pharmacovigilance and Risk Management

Pharmacovigilance and Risk Management comprises set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicinal and therapeutic products including the assessment of the effectiveness of their clinical interventions and combination therapies. Drug industry need to promote companies in pharmacovigilance practice to use information technology and to review softwares used in pharmacovigilance and clinical trials. Monitoring unlicensed, off labels and orphan drugs is major task in risk management. Many experts from different pharmacovigilance CRO's , pharmacovigilance service providers and industrial delegates are participating in this conference to share their knowledge and discuss about the new updates.

Related Pharmacovigilance Conferences Pharmacovigilance Meetings

9th Pharmacology Conference September 04-06, 2017 Paris, France; 3rd Conference on Clinical Research September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Analysis Conference October 02-03, 2017 at Vienna, Austria; 5th Conference on Pain Research October 05-06, 2017 London, UK; Pharmaceutical Biotechnology Conference December 07-09, 2017 Madrid, Spain;  Pharmaceutical Sciences Conference  February 26- 27, 2018 London, UK; 16th Novel Drug Delivery Systems Conference March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th  Conference  on  Marine Drugs June 11-13, 2018 Rome, Italy

Related Associations or Societies:

The International Society of Pharmacovigilance (ISOP), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Association of Clinical Research Organization (ACRO), Indian Pharmaceutical AssociationAssociation of Clinical Research

Track 4: Good Pharmacovigilance Practice

The role of Good Pharmacovigilance Practice and Pharmacoepidemiology in Risk Management is mainly to increase the probability of beneficial effects of a drug in a population than the probability of adverse effects and to maintain the Good Reporting Practices by avoiding the major problems in risk management. Also it is important to concentrate on Signal investigation by gathering the information on new or unknown drug effects that is potentially caused by a medicine and that finally should lead to ensuring safety. The pharmacovigilance and clinical trials services providing companies should have the Pharmacovigilance certification.

Related Pharmacovigilance ConferencesPharmacovigilance Meetings

9th Pharmacology Conference September 04-06, 2017 Paris, France; 3rd  Conference on Clinical trials September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Pain Research Conference October 05-06, 2017 London, UKPharmaceutical Biotechnology Conference December 07-09, 2017 Madrid, Spain; Pharmaceutical Sciences in  Pharma Industry Conference February 26- 27, 2018 London, UK; Pharmaceutics and  Drug Delivery Systems Conference March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th European Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th  Conference on Natural Products June 11-13, 2018 Rome, Italy

Related Associations or Societies:

American Association of Pharmaceutical ScientistsIndian Pharmaceutical AssociationAssociation of Clinical ResearchThe International Society of PharmacovigilanceCanadian Society of Pharmaceutical Sciences (CSPS), Association of Clinical Research Organization (ACRO)

Track 5: Pharmacy Practices and its Challenges

Pharmacy practice is the field of pharmacy which involves developing the professional roles of pharmacists. It includes Disease-state management, Clinical drug interventions, Pharmacy professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, drug abuse prevention, prevention of drug interactions or minimisation of adverse events and drug incompatibility and community pharmacy.

Related Pharmacovigilance ConferencesPharmacovigilance Meetings

5th Pharmaceutical Sciences Conference; 8th Conference on Pharmacology, August 07-09, 2017, Paris, France; 3rd  Conference on Clinical Research September 20-21 Dublin, Ireland; 8th Pharmaceutical Analysis Conference  September 25-27, 2017 at Vienna, Austria

Related Associations or Societies:

The Society of Clinical Research Associates (SOCRA), Clinical Research SocietySociety for Clinical Trials (SCT), Associates of Clinical ResearchAssociation of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)

Track 6: Biopharmaceutical Sciences 

In Clinical Pharmacology and Biopharmaceutics track we will discuss about the Rational drug management of cancer, diabetes and cardiovascular disorders, and Management of psychiatric disorders and autoimmune disorders. Along with clinical trials Bioavailability and bioequivalence studies also plays major role in clinical research.The global market for Biopharmaceutics in 2013 was $305.1 million, which is expected to reach about $326.3 million by year-end 2014. The projected PAT instrumentation market is expected to be valued at around $450.6 million by 2019 at a compound annual growth rate (CAGR) of 6.7% for the period of 2014 to 2019.

Related Pharmacovigilance ConferencesPharmacovigilance Meetings

9th Pharmacology Conference September 04-06, 2017 Paris, France; 3rd  Clinical trials Conference September 20-21, 2017 Dublin, Ireland; 9th Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th  Conference on  Pain Research October 05-06, 2017 London, UK; 20th Conference on Biotechnology December 07-09, 2017 Madrid, Spain; Pharma Industry Conference February 26- 27, 2018 London, UK; 16th Drug Delivery Conference March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Conference on Pharma  May 07-09, 2018 Frankfurt, Germany; 4th  Conference on  Drugs and Natural Products June 11-13, 2018 Rome, Italy

Related Associations or Societies:

Association of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS), Pharmaceutical Information and Pharmacovigilance Association (PIPA), American Association of Pharmaceutical; ScientistsAmerican Society of Pharmacognosy

 Track 7: Clinical Trials on Various Disorders

Clinical Trials on various diseases include Clinical Trials in long chronic diseases like AIDS, Benign and Malignant Tumours, Cardiovascular diseases, Diabetes, Clinical Trials on Monoclonal and Polyclonal Antibodies, Neurological, Physiological and Psychological Disorders

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Pharmacology Conference September 04-06, 2017 Paris, France; 3rd  Clinical trials Conference September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Conference on Pain Research and Management October 05-06, 2017 London, UK; 20th Pharmaceutical Biotechnology Conference December 07-09, 2017 Madrid, Spain; 12th Conference on Sciences  February 26- 27, 2018 London, UK; 16th  Pharmaceutics and  Novel Drug Delivery Systems Conference March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th  Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th   Natural Products Conference June 11-13, 2018 Rome, Italy

 Related Associations or Societies:

The Society of Clinical Research Associates (SOCRA), Clinical Research SocietySociety for Clinical Trials (SCT), Associates of Clinical ResearchAssociation of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)

Track 8: Data Quality Management and Analysis

Good data quality management in pharmacovigilance can be relied only on information gathered from the collection of individual case safety reports and other pharmacoepidemiological data. Quality management consists of quality planning, quality control, quality assurance and quality improvements. The pharmacovigilance data processing cycle starts with data collection and, in computerised systems, data entry; the next step is data storage and maintenance; followed by data selection, retrieval and manipulation. The resulting data output is analysed and assessed. Finally, conclusions are drawn and decisions are made. The quality of a pharmacovigilance data system can be defined as a measure of excellence or a state of being free from defects, deficiencies and significant variations and the  data quality management includes all the activities that organizations use to direct, control and coordinate the quality of data.

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Conference on Pharmacology September 04-06, 2017 Paris, France; 3rd Clinical Research Conference September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Conference on Pain Research October 05-06, 2017 London, UK; 20th Conference on Pharmaceutical Biotechnology December 07-09, 2017 Madrid, Spain; 12th Congress on Pharmaceutical Sciences and in Pharma Industry  Conference February 26- 27, 2018 London, UK; 16th  Drug Delivery Systems Conference March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th  Conference on  Marine Drugs June 11-13, 2018 Rome, Italy

Related Associations or Societies:

Pharmaceutical Information and Pharmacovgilance Association (PIPA), American Association of Pharmaceutical; ScientistsAmerican Society of Pharmacognosy , Association of Clinical Research Organization (ACRO), Society for Clinical Trials (SCT), Association of Clinical Research

Track 9: Pharmacovigilance Significance & Scope

Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to know what is pharmacovigilance. This track gives a brief discussion on Pharmacovigilance role in healthcare system. Pharmacovigilance legislation gives an outlook on the rules and laws to follow in Pharmacovigilance practice. The Role of pharma industries in the improvement of pharmacovigilance system is very crucial to maintain the safety data, Detection and Evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines.

Related Pharmacovigilance ConferencesPharmacovigilance Meetings

9th Pharmacology Conference September 04-06, 2017 Paris, France; 3rd Advanced Clinical Research Conference September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Pain Research Conference October 05-06, 2017 London, UK; 20th  Pharmaceutical Biotechnology Conference December 07-09, 2017 Madrid, Spain; 12th Conference on Pharma Industry February 26- 27, 2018 London, UK; 16th Conference on  Novel Drug Delivery March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th  Conference on Marine Drugs  June 11-13, 2018 Rome, Italy

Related Associations or Societies:

American Association of Pharmaceutical ScientistsIndian Pharmaceutical AssociationAssociation of Clinical ResearchThe International Society of PharmacovigilanceCanadian Society of Pharmaceutical Sciences (CSPS), Association of Clinical Research Organization (ACRO)

Track 10: Diversity in Industrial Clinical Trials and Clinical Research

The clinical trial industry is constantly evolving with diversified clinical research technologies and new clinical studies are being launched at an ever-growing pace. Clinical trials have always been a vital part of the medicine development process, as they provide clinical data on the best ways for treating pathological disorders and diseases. The importance of diversity in industrial clinical trials and clinical research is to ensure that industrial clinical trials are doing due diligence and being as strategic as possible in their results. This diversity makes us to better understand the unmet medical needs of patients.

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Conference on Pharmacology September 04-06, 2017 Paris, France; 3rd Conference on Clinical Research September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Conference on Pain Research October 05-06, 2017 London, UK; Conference on Biotechnology December 07-09, 2017 Madrid, Spain; 12th Pharmaceutical Sciences  Conference February 26- 27, 2018 London, UK; 16th Conference on  Pharmaceutics  March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th   Conference on  Marine Drugs  June 11-13, 2018 Rome, Italy

Related Associations or Societies:

Society for Clinical Trials (SCT), Association of Clinical ResearchThe Society of Clinical Research AssociatesAssociation of Clinical Research OrganizationClinical Research SocietyIndian Society for Clinical Organization Research (ISCR)

Track 11: Clinical Research and Statistics

In Clinical Research, Statistics plays a prominent role in regulatory submissions. Statistical analysis of Pharmacovigilance can be achieved by several guidelines mainly ICH guidelines. Adverse Drug Reactions reports can also be considered for the regulatory submission.

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Pharmacology Conference September 04-06, 2017 Paris, France; 3rd Conference on Clinical Research September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Conference on Pain Research and Management October 05-06, 2017 London, UK; 20th Conference on Biotechnology December 07-09, 2017 Madrid, Spain; 12th Pharma Industry Conference February 26- 27, 2018 London, UK; 16th Conference Novel Drug Delivery Systems March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th  Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th  Conference on   Natural Products  June 11-13, 2018 Rome, Italy

Related Associations or Societies:

American Association of Pharmaceutical ScientistsIndian Pharmaceutical AssociationAssociation of Clinical ResearchThe International Society of PharmacovigilanceCanadian Society of Pharmaceutical Sciences (CSPS), Association of Clinical Research Organization (ACRO)

Track 12Case Report in Clinical Trials

Case Report in Clinical Trials plays a key role in Clinical Research. Case reports may be on unexpected association between diseases, disorders or symptoms. An unexpected event in the course of observing, treating a patient, possibilities of  pathogenesis of a disease or an adverse effect. Unique or rare salient features of a disease or therapeutic approaches or a notable variation of the anatomical structures.

Related Pharmacovigilance Congress | Pharmacovigilance Events

3rd Conference on Clinical trials September 20-21 Dublin, Ireland;  5th Conference on Pharmacology September 25-26, 2017 Singapore; 8th Pharmaceutical Analysis Conference  September 25-27,2017 Vienna, Austria

Related Associations or Societies:

The Society of Clinical Research Associates (SOCRA), Clinical Research SocietySociety for Clinical Trials (SCT), Associates of Clinical ResearchAssociation of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)

Track 13: Drug Safety

Drug Safety heavily focuses on adverse drug reactions which are defined as any response to a drug which is noxious and unintended, including lack of efficacy. Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Information received from patients and healthcare providers via pharmacovigilance agreements (PVAs), as well as other sources such as the medical literature, plays a critical role in providing the data necessary for pharmacovigilance to take place. Ultimately, drug safety is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients. Companies must conduct a comprehensive drug safety and pharmacovigilance audit to assess their compliance with worldwide laws, regulations, and guidance.

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Conference on Pharmacology September 04-06, 2017 Paris, France; 3rd Conference on Clinical Research September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th Pain Research and Management  Conference October 05-06, 2017 London, UK; 20th Conference on Pharmaceutical Biotechnology December 07-09, 2017 Madrid, Spain; 12th Conference on Pharmaceutical Sciences February 26- 27, 2018 London, UK; 16th  Conference on Pharmaceutics March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th  Conference on  Marine Drugs June 11-13, 2018 Rome, Italy

Related Associations or Societies:

Society for Clinical Trials (SCT), Association of Clinical ResearchThe Society of Clinical Research AssociatesAssociation of Clinical Research OrganizationClinical Research SocietyIndian Society for Clinical Organization Research (ISCR)

 Track 14: Clinical Data Base Management

There is an advantage in centralising all safety data, clinical data, analysis and reporting with one provider. Pharmacovigilance Software tool provides comprehensive analysis of adverse events arising from the use of Pharmaceutical products (Medicinal Product, Medical Device, Vaccines, Non-Drug Therapy and Veterinary Medicinal Product). The drug safety database allows the risk- benefit analysis of medicinal products taking into account new and emerging information, in the context of cumulative information. Pharmacovigilance since beginning has been a compliance driven activity, wherein your regulatory compliance determines company’s risk assessment scores. A drug safety database offers scheduling of alerts for expedited cases, follow-up cases and PSUR/PADER reports submission to meet regulatory timeline compliance.

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Conference on Pharmacology September 04-06, 2017 Paris, France; 3rd  Conference on Clinical trials September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th  Conference on Pain Research October 05-06, 2017 London, UK; 20th  Conference on Biotechnology December 07-09, 2017 Madrid, Spain; 12th Conference on Pharmaceutical Sciences February 26- 27, 2018 London, UK; 16th  Conference on Novel Drug Delivery March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th  Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th  Conference on  Marine Drugs June 11-13, 2018 Rome, Italy

Related Associations or Societies:

The Society of Clinical Research Associates (SOCRA), Clinical Research SocietySociety for Clinical Trials (SCT), Associates of Clinical ResearchAssociation of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)

Track 15: PV Consulting’s and Business opportunity

Due to the changing resources necessary to fulfil the regulatory requirements, some companies also choose to outsource or out task regulatory affairs to external service providers. Regulatory Affairs department is constantly evolving and growing and is the one which is least impacted during the Acquisition and Merger, and also during recession. The global pharmacovigilance market and Business opportunity was valued at USD 2,408.0 million in 2013 and is expected to grow at a CAGR of 12.6% during the forecast period. Phase III clinical trials market was the second largest and was valued at over USD 750.0 million in 2013.

Related Pharmacovigilance ConferencesPharmacovigilance Meetings

9th Conference on Pharmacology September 04-06, 2017 Paris, France; 3rd Conference on Advanced Clinical Research September 20-21, 2017 Dublin, Ireland; 9th Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th  Conference on Pain Research and Management October 05-06, 2017 London, UK; 20th  Conference on Pharmaceutical  December 07-09, 2017 Madrid, Spain; 12th Conference on Pharma Industry February 26- 27, 2018 London, UK; 16th  Conference on Drug Delivery Systems March 19-21, 2018 Berlin, Germany; 11th  Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th   Conference on Natural Products June 11-13, 2018 Rome, Italy

Related Associations or Societies:

Association of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS), Pharmaceutical Information and Pharmacovgilance Association (PIPA), American Association of Pharmaceutical; ScientistsAmerican Society of Pharmacognosy

Track 16: Regulatory Affairs

Regulatory Affairs for clinical trials is the major part in the clinical trials approaches. Every clinical trial must be analysed according to the Regulatory Affairs Guidelines. There are several Regulatory Affairs departments depending upon the countries within ever growing pace of companies. Global Harmonization in standards has led to consistent approach in regulatory submissions and hence its review.

Related Pharmacovigilance Congress | Pharmacovigilance Events

9th Conference on Pharmacology September 04-06, 2017 Paris, France; 3rd  Conference on Advanced Clinical Research September 20-21, 2017 Dublin, Ireland; 9th  Pharmaceutical Chemical Analysis Conference October 02-03, 2017 Vienna, Austria; 5th  Conference on Pain Research October 05-06, 2017 London, UK; 20th  Conference on Biotechnology  December 07-09, 2017 Madrid, Spain; 12th  Conference on Pharmaceutical Sciences February 26- 27, 2018 London, UK; 16th  Conference Novel Drug Delivery Systems March 19-21, 2018 Berlin, Germany; 11th Biosimilars Conference April 26-27, 2018 Rome, Italy; 10th Pharma Conference May 07-09, 2018 Frankfurt, Germany; 4th   Conference on Marine Drugs  June 11-13, 2018 Rome, Italy

Related Associations or Societies: 

The International Society of Pharmacovigilance (ISOP), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Association of Clinical Research Organization (ACRO), Indian Pharmaceutical AssociationAssociation of Clinical Research

Track 17: Entrepreneurs Investment Meet

Initial investment, capital requirements, business financing, current trends and the amount of time will take to get your business up and running. Pharmacovigilance 2017 focus in collaboration and communication among the Pharma Professionals, Business Entrepreneurs, CEO’s and Pharma Industrial Persons

About the Conference

Conference Series  is organizing splendorous Pharmaceutical conferences welcomes you to attend the 11th International Conference and Exhibition on Pharmacovigilance & Drug Safety  to be held during June 21-22, 2018 in London, UK. It focuses on the advancements in Pharmacovigilance, Risk Management, Drug Safety.

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 11th International Conference and Exhibition on Pharmacovigilance & Drug Safety  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. 

Why to attend???

With members from around the world focused on learning about Pharmacovigilance and its advances; this is your best opportunity to reach the largest assemblage of participants from the Pharmacovigilance community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive named recognition at this 3-days event. World-Renowned Speakers, the most recent techniques, developments, and the newest updates in Pharmacovigilance are Hallmarks of this Conference.

Target Audience:

  • Pharmacovigilance Students, Scientists
  • Pharmacovigilance Researchers
  • Pharmacovigilance Faculty
  • Medical Colleges
  • Pharmacovigilance Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software Developing Companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

 

Market Analysis

Pharmacovigilance 2018 welcomes attendees, presenters, and exhibitors from all over the world to Munich, Germany. We are delighted to invite you all to attend and register for the “11th International Conference and Exhibition on Pharmacovigilance & Drug Safety” which is going to be held during June 21-22, 2018 in London, UK. The Organizing Committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Pharmacovigilance 2018, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Pharmacovigilance 2018 Organizing Committee will look forward to meet you at Munich, Germany.

For more details please visit- http://market-analysis.conferenceseries.com/pharmacovigilance-market-reports

Importance and Scope: Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. The main purpose of pharmacovigilance is to improve the patient's safety and enhance his care in terms of the use of medicines, including paramedical interventions. Pharmacovigilance also supports public health programs by providing reliable information for the efficient assessment of the risk-benefit profile of medicines, contribute to the assessment of benefits, uses, side effects, harm, effectiveness and risk of medicines, encouraging the safe, rational and more effective (including cost-effective) use of various medicines. Promote education, understanding and clinical training in Pharmacovigilance and its effective availability to the public.

Why Munich, Germany?

The Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020. Increasing incidence rates of adverse drug reaction (ADR) and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development. Additionally, health regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) are now emphasizing on electronic submission of data which is also expected to drive the pharmacovigilance market.

Pharmacovigilance Market, by Phases of Drug Development:

  • Preclinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV or Post Marketing Surveillance

Pharmacovigilance Market, by Type of Methods:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Pharmacovigilance Market, by Type of Service:

  • In-House
  • Contract Outsourcing

 Conference Highlights

  • Drug Safety
  • Adverse Drug Reactions
  • Pharmacovigilance Significance & Scope
  • Good Pharmacovigilance Practice
  • Pharmacovigilance and Risk Management
  • Pharmacokinetics and Pharmacodynamics
  • Pre-Clinical and Clinical Trials
  • Clinical Trials on Various Disorders
  • Diversity in Industrial Clinical Trials and Clinical Research
  • Clinical Research and Statistics
  • Case Report in Clinical Trial
  • Data Quality Management and Analysis
  • PV Data Base Managemaent
  • PV Consultings And Bussiness Opportunity
  • Regulatory Affairs
  • Growth Strategies in Pharma
  • Pharmacy Practices and its Challenges
  • Entrepreneurs Investment Meet    

 

Global pharmacovigilance market, by clinical trials, 2012 – 2020 (USD Million)

   

Past Conference Report

Pharmacovigilance 2017

Pharmacovigilance-2017 Report

Pharmaovigilance 2017 past Conference Report

Thanks to all of our wonderful Speakers, Conference Attendees and Sponsors; Pharmacovigilance 2016 Conference was our best ever!

The “9th International Conference and Exhibition on Pharmacovigilance”, hosted by the Conferenceseries LLC was held on July 17-18, 2017 in Holiday Inn Munich - City Centre
Hochstraße 3, 81669 München, Germany. Generous response and active participation was received from the scientists, researchers and leaders from clinical, government organizations, students who made this conference as one of the most successful and productive events in 2017.

With the support and guidance of Organizing Committee Members and Editorial Board Members and astonishing presentations of all participants this prominent summit became more impressive.

Conferenceseries LLC would like to convey a great appreciation to Keynote speakers Jorge I Gonzalez Borroto, Essam Ghanem, Anika Staack and Flic Gabbay.

Honourable guests and Keynote Speakers supported this event with sustainable excitement for grand success of this prominent conference. Also it is our pleasure to announce next 12th International Conference and Exhibition on Pharmacovigilance & Drug Safety which will be held during June 21-22, 2018, in London UK with the theme “Global Pharmacovigilance Approaches and Innovations for Patient Benefit Risk Management”.

We hope your favorable support will make next conference also one more grand success.

For more details about Pharmacovigilance 2018 visit

http://pharmacovigilance.pharmaceuticalconferences.com/

 


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 21-22, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Pharmacovigilance Journal of Clinical & Experimental Pharmacology Journal of Clinical Trials

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos